×

Additional COVID-19 booster recommended

The Maui News

The Hawai’i Department of Health is supporting the latest recommendations announced Wednesday by the Centers for Disease Control and Prevention to allow an additional dose of the COVID-19 bivalent booster for individuals at increased risk for severe infection.

The CDC’s announcement also simplifies vaccination schedules to allow bivalent vaccines to be used for primary vaccination series, as well as boosters, a news release said on Thursday.

 “These simplified recommendations make it even easier to protect yourself and your family from severe COVID-19 illness and death,” said State Epidemiologist Dr. Sarah Kemble. “COVID-19 is still circulating, and we have seen a recent rise in hospitalizations. We had 10 COVID-19 deaths reported in the last week. It is definitely worth it to get a booster dose now, if you are eligible. This is particularly important for kupuna and people who are immunocompromised.”

The changes are:

• Everyone 6 years and older who has not received a bivalent vaccine dose should receive one, regardless of what vaccine was used for their primary series.

• Those who already received a bivalent vaccine booster dose do not need to take any action, unless they are 65 years or older or immunocompromised.

• Adults 65 years and older can now receive a second bivalent vaccine booster dose at least four months after their initial bivalent dose.

• People who are immunocompromised may receive additional bivalent vaccine booster doses and should consult their healthcare provider to determine the best timing for additional doses.

• Bivalent vaccine can be used for all primary series and booster doses in adults and children 6 months and up. The original monovalent COVID-19 mRNA COVID-19 vaccines will no longer be recommended for use in the United States.

DOH sent out a notice Tuesday to all Hawaii COVID-19 vaccine providers to inform them of the FDA authorization changes.

More information about locating vaccine providers and COVID-19 vaccination guidance can be found at vaccines.gov.

Starting at $4.62/week.

Subscribe Today